top of page
  • Ahmad Hidayat

Transforming the Way Pharmaceutical Companies Do Business: How Our Pharma TIMUR Platform Can Help


Introduction


The COVID-19 pandemic has thrown the world into uncertainty, and the pharmaceutical industry is no exception. While the demand for certain drugs and medical supplies has skyrocketed, supply chain challenges and reduced demand for other products have hurt the financial performance of many pharmaceutical companies. To stay ahead in this highly competitive industry, companies must understand the evolving needs of patients, adapt to changing market conditions, and develop strategies that set them apart from their competitors.


Enter our revolutionary end-customer market insight platform, Pharma TIMUR (The insightful Market Uplifting and Reinforcement). Developed in partnership with AdMedika and Integrindos, this powerful Pharma TIMUR Platform offers a unique and comprehensive approach to understanding the needs and preferences of pharmaceutical companies' end customers. By analyzing data from over 11,000 medication identifiers from over 1,200 healthcare facilities from over 200 cities in Indonesia, this platform provides valuable insights into market trends and patterns, enabling companies to make informed business decisions and stay ahead of the competition.


But that's not all! Pharma TIMUR Platform also offers solutions to help optimize marketing strategies and drive growth. By leveraging advanced data analytics capabilities, pharmaceutical companies can target specific market segments, craft personalized campaigns, and optimize resources to get the most out of their marketing efforts.


The Impact of COVID-19 on the Pharmaceutical Industry: Challenges and Opportunities


The COVID-19 pandemic has significantly impacted all industries, including the pharmaceutical industry, with challenges and opportunities arising as a result.


Although the COVID-19 pandemic has led to a significant increase in the demand for some drugs and medical supplies, this increased demand for drugs and medical supplies has been offset by challenges in the supply chain and reduced demand for other products. Consequently, the COVID-19 pandemic has also harmed the financial performance of many pharmaceutical companies.


The COVID-19 pandemic has significantly impacted many pharmaceutical companies to maintain revenue and profitability. While the increased demand for COVID-19-related products has helped offset some of these losses, pharmaceutical companies need to maintain revenue. Also, the pharmaceutical industry is highly competitive, and companies must stay ahead to stay ahead of competitors.


Unlock the Power of Enhanced Market Understanding


The COVID-19 pandemic has also highlighted the need for effective treatments and therapies for various diseases and conditions to meet the evolving needs of patients. The COVID-19 pandemic has also led to significant market conditions changes, such as consumer behavior shifts and new regulatory frameworks. As a result, pharmaceutical companies must recognize the market insights of non-COVID-19 related products so that they can continue to develop and distribute drugs and treatments that meet the evolving needs of patients. By observing the market dynamics of non-COVID-19 related products, pharmaceutical companies can identify opportunities for growth and innovation and develop strategies to differentiate themselves from their competitors.


Understanding the nature of the prescribed drug is essential for pharmaceutical companies because it allows them to target their marketing efforts better and develop products that are well-suited to the market's needs. Pharmaceutical companies can identify opportunities to develop or improve new products by knowing the medication plans and regimens. This situation can help them stay competitive and increase their sales. Additionally, understanding the treatment regimen dynamics can help pharmaceutical companies identify potential safety issues or adverse reactions to their products, allowing them to address these concerns and maintain the trust of patients and healthcare providers.


Pharmaceutical companies would benefit from knowing the clinical recommendation in a city area as it would help them tailor their marketing strategies to promote their products and services better. Knowing the treatment plans would allow them to understand better which drugs are being prescribed and where and provide insight into how physicians make decisions when prescribing medications. The development of promotional campaigns and strategies can use the information tailored to the area's specific needs or physicians.


Introducing Our Revolutionary Approach to Achieving a Deeper Understanding of the Market: The Pharma TIMUR Platform


We are excited to present our Pharma TIMUR Platform. As a result of a joint development solution with PT. Administrasi Medika (AdMedika) - a leader in health administration and digital services with Integrindos, which has vast experience in data analytics in the pharmaceutical industry.



Our Pharma TIMUR Platform is unlike any other on the market, offering a unique and niche approach to understanding the needs and preferences of the pharmaceutical companies' end customers. With this powerful tool, pharmaceutical companies can gain valuable insights into the trends and patterns that drive the market, empowering the strategy to make informed business decisions and stay ahead of the competition.


Also, our Pharma TIMUR Platform offers practical, actionable solutions to help the pharmaceutical company optimize its marketing strategies and drive growth. By leveraging our advanced data analytics capabilities, it targets specific market segments, crafts personalized campaigns, and optimizes resources to get the most out of the marketing efforts.


A Comprehensive Platform for Gaining Valuable Insights and Optimizing Marketing Strategies


This unparalleled platform is a goldmine for pharmaceutical companies, providing unprecedented insight into the healthcare experiences of individuals with employer-provided medical coverage in Indonesia's top 200 cities. With a massive dataset featuring over 11,000 medication identifiers and data from more than 1,200 healthcare facilities, this platform processes an astounding 70 million monthly transactions. It is the entire massive amount of data available on this platform. It is unparalleled in the pharmaceutical industry and will be a valuable resource for companies looking to stay ahead of the competition.


This ground-breaking dataset offers incomparable detail, including information on the comprehensive treatment regimens of individuals with employer-provided medical coverage. By delving into this treasure trove of data, pharmaceutical companies can gain unmatched insights into the healthcare system in Indonesia on the specific segment and the specific needs of these individuals. These insights will allow them to create highly targeted and effective product strategies perfectly tailored to meet the market's demands and deliver the highest quality. Simply put, this dataset is a game-changer for the pharmaceutical industry.

Source: a dashboard snapshot

The takeaway


Don't miss out on the opportunity to unlock the power of enhanced market understanding and stay ahead of the competition. Our revolutionary end-customer market insight platform - Pharma TIMUR, offers a comprehensive and unique approach to understanding the needs and preferences of your end customers, as well as practical solutions to optimize your marketing strategies and drive growth. With advanced data analytics capabilities and data from over 11,000 medication identifiers and more than 1,200 healthcare facilities, this platform is your key to success in today's complex and ever-changing market. Contact us today to learn more and get started.

59 views0 comments

Recent Posts

See All

Call to action: digitalization. The COVID-19 pandemic has pushed Indonesia to take steps to become more competitive and innovative. One of their most important steps is transforming the healthcare sec

bottom of page